For Patients: Clinical Trials
Publications
Careers
Contact Us

About INOVIO
DNA Medicines Technology
DNA Medicines Pipeline
Investors & Media
For Patients: Clinical Trials
Publications
Careers
Contact Us

About INOVIO
DNA Medicines Technology
DNA Medicines Pipeline
Investors & Media
For Patients: Clinical Trials
Publications
Careers
Contact Us

xxx

INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800

SUBSCRIBE FOR UPDATES FROM INOVIO
Register to receive email alerts for INOVIO press releases

About Inovio
DNA Medicines Technology
DNA Medicines Pipeline
Investors & Media
For Patients
Publications
Careers
Contact Us

Safe Harbor Statement
Expanded Access
Privacy Policy
Terms & Conditions

© Copyright 2025 INOVIO Pharmaceuticals. All rights reserved.